Latest TULSA Stories
Profound Medical Receives IDE Approval from FDA to Conduct TULSA Clinical Trial for New Treatment for Localized Prostate Cancer
Profound Medical is pleased to announce that the FDA has granted it IDE approval to conduct a clinical study of its device for the treatment of localized prostate cancer. Toronto,
Word of the Day
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.
The word 'logocentrism' is a blend of logo- + centrism.